Subscribe to Search results

A report on the outcome of the lookback exercise in England since 1995 stated that 4,432 recipients of 6,687 blood components were identified, and 61% (2717) of identified recipients were known to be dead at the time of tracing.

Published on:

Dr Kieran Morris sought the assistance of Dr Frank Jones to identify patients who may have received contaminated blood following two donors who came after a long interval and were found to be HCV antibody positive.

Published on:

Dr Cash in a letter to Dr Gunson stated that the question arose whether they should be doing anti-HCV tests on the relevant donation aliquots so that they could more readily locate "the offending donor" with a view to taking him/her off the panel.

Published on:

It was confirmed by the Scottish Office Department of Health that the steps that had been taken regarding the lookback exercise already were sufficient.

Published on:

At the meeting of the SNBTS directors, it was agreed that Professor Cash would write to the ACVSB asking that "careful consideration" be given to introducing a Hepatitis C lookback.

Published on:

A press release from Tom Sackville stated that "procedures have been established which make it possible to trace those at risk".

Published on:

A press release from Tom Sackville recorded that the Minister had asked Dr Metters, chair of the Advisory Committee and the Deputy CMO, to bring together an ad hoc working party of experts to draw up guidance on the procedure for undertaking lookback and for counselling those identified as being at risk, as well as guidance on the treatment options available.

Published on:

Professor Cash recommended that where a regular blood donor was confirmed as Hepatitis C positive "the fate of previous donations is determined and 'lookback' initiated in accordance with SNBTS policy."

Published on:

The outcome of the Hepatitis C lookback in England was formally reported. 50% of tested recipients were found to be infected with Hepatitis C. 4,432 recipients of 6,687 blood components were identified.

Published on:

The Scottish Office wrote to SNBTS asking them to take forward "as expeditiously as possible" a Hepatitis C lookback for all of Scotland and to keep the SHHD informed.

Published on:

The Standing Advisory Committee on Transfusion Transmitted Infections noted that "the issue needs resolution and will be examined in more detail by a group to be convened to consider it further."

Published on:

Dr Gunson and Dr Cash "agreed [that]...it would not, after we start anti-HCV donation screening, be appropriate to introduce a systematic look-back programme on previous recipient - as was done for HIV-1."

Published on:

Professor Cash, on behalf of SACTTI, produced a paper for the MSBT on the merits of adopting a Hepatitis C lookback policy. It stated that a Hepatitis C lookback could be based on the current procedures of HIV lookback.

Published on:

Dr Gunson of the National Blood Transfusion Service wrote to Professor Cash of the Scottish NBTS, advising him of discussions had at ACVSB and plans to table the subject in upcoming meetings, and the intention to ask John Craske for a copy of the questionnaire for counselling as compiled by Dr Julia Heptonstall.

Published on:

In a letter to Dr A Keel, Professor Franklin provided an update on the HCV lookback exercise, particularly the lack of funding needed to trace some patients, and considered the issue of RIBA indeterminates.

Published on:

In a letter to all doctors, Scottish Health Department CMO, Dr R E Kendell, provided guidance relating to the recently announced HCV lookback exercise and sought their assistance in identifying patients infected with HCV through blood transfusion.

Published on:

At a meeting of the SNBTS Medical & Scientific Committee It was recorded that "in the light of national events, it was agreed no 'Look Back' should be introduced at present."

Published on:

At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented a report on the HCV lookback.

Published on:

At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented the SACTTI's paper on Hepatitis C Lookback. Professor Arie Zuckerman raised concerns that interferon was not licensed for treatment of Hepatitis C-related disease and ribavirin was noted to be "even more costly."

Published on:

At a meeting, Dr Gillon briefed the SNBTS Medical and Scientific Committee on the Hepatitis C lookback.

Published on: